Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand

Myron Cohen, MD

Yeargan-Bate Eminent Professor of Medicine, Microbiology and Epidemiology Associate Vice Chancellor for Medical Affairs and Global Health Director, Institute for Global Health and Infectious Diseases
University of North Carolina at Chapel Hill

Dr. Cohen is a Fellow of the American College of Physicians, the Infectious Disease Society of America, and the American Society of Microbiology. He is a member of the National Academy of Medicine, the American Society of Clinical Investigation, and the American Association of Physicians. Dr. Cohen serves as the Director of the UNC Institute for Global Health and Infectious Disease, and as Associate Vice Chancellor for Global Health.

Dr. Cohen’s research has focused on the transmission and prevention of transmission of HIV. Dr. Cohen is the architect and Principal Investigator of the multinational HPTN 052 trial, which established that antiretroviral treatment of people with HIV infection can prevent the sexual transmission of the virus when ART is taken as prescribed and viral suppression is achieved and maintained. This work was recognized by Science Magazine as the “Breakthrough of the Year” in 2011.

Serving as Co-PI of the NIH HIV Prevention Trials Network, Dr. Cohen has focused on development of antiviral agents and broad neutralizing antibodies for pre-exposure prophylaxis of HIV (PrEP).

With the onset of the COVID-19 pandemic in 2020 Dr. Cohen was appointed to the Leadership Committee of the NIH COVID Prevention Network (CoVPN). Dr. Cohen focused on monoclonal antibodies for prevention of COVID-19. He led studies that showed monoclonal antibodies could prevent COVID-19 infections.

Dr. Cohen is the author of more than six hundred publications and one book. He has written extensively about the prevention of sexually transmitted infections, HIV infection and COVID-19. Much of Dr. Cohen’s research has been conducted in resource limited countries. Dr. Cohen is a paid speaker for Gilead Sciences, Inc.

Disclosure information not submitted.

Presentation(s):